MetLife Investment Advisors LLC purchased a new position in shares of Davita Inc (NYSE:DVA) during the fourth quarter, HoldingsChannel reports. The fund purchased 46,840 shares of the company’s stock, valued at approximately $3,384,000.
Several other hedge funds have also modified their holdings of DVA. OppenheimerFunds Inc. increased its position in shares of Davita by 5,292.6% during the fourth quarter. OppenheimerFunds Inc. now owns 1,873,918 shares of the company’s stock worth $135,391,000 after purchasing an additional 1,839,168 shares in the last quarter. Millennium Management LLC increased its position in shares of Davita by 239.9% during the fourth quarter. Millennium Management LLC now owns 2,024,308 shares of the company’s stock worth $146,256,000 after purchasing an additional 1,428,810 shares in the last quarter. Bridger Management LLC acquired a new position in shares of Davita during the fourth quarter worth $52,339,000. International Value Advisers LLC acquired a new position in shares of Davita during the fourth quarter worth $45,175,000. Finally, Schroder Investment Management Group increased its position in shares of Davita by 769.0% during the third quarter. Schroder Investment Management Group now owns 434,191 shares of the company’s stock worth $25,387,000 after purchasing an additional 384,224 shares in the last quarter. 85.80% of the stock is currently owned by institutional investors and hedge funds.
In other Davita news, insider James K. Hilger sold 3,572 shares of the company’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $78.95, for a total value of $282,009.40. Following the sale, the insider now directly owns 33,649 shares of the company’s stock, valued at $2,656,588.55. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 2.10% of the stock is currently owned by corporate insiders.
Davita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, February 13th. The company reported $0.92 earnings per share for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.02). The company had revenue of $2.78 billion for the quarter, compared to analysts’ expectations of $3.90 billion. Davita had a net margin of 4.65% and a return on equity of 12.86%. During the same period last year, the firm earned $0.98 earnings per share. sell-side analysts anticipate that Davita Inc will post 4.15 EPS for the current fiscal year.
A number of brokerages have recently issued reports on DVA. Bank of America reaffirmed a “buy” rating and set a $92.00 price target (up from $85.00) on shares of Davita in a research report on Thursday, January 11th. JPMorgan Chase & Co. boosted their price objective on shares of Davita from $4.90 to $84.00 and gave the company a “strong-buy” rating in a report on Thursday, December 7th. SunTrust Banks set a $70.00 price objective on shares of Davita and gave the company a “hold” rating in a report on Thursday, December 7th. KeyCorp reissued a “hold” rating on shares of Davita in a report on Wednesday, December 6th. Finally, Robert W. Baird raised shares of Davita from a “neutral” rating to an “outperform” rating and boosted their price objective for the company from $63.00 to $82.00 in a report on Tuesday, December 12th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating, four have given a buy rating and two have assigned a strong buy rating to the company’s stock. Davita presently has a consensus rating of “Hold” and an average target price of $79.30.
COPYRIGHT VIOLATION WARNING: “MetLife Investment Advisors LLC Purchases Shares of 46,840 Davita Inc (DVA)” was reported by WKRB News and is the sole property of of WKRB News. If you are viewing this story on another site, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this story can be read at https://www.wkrb13.com/2018/03/31/metlife-investment-advisors-llc-purchases-shares-of-46840-davita-inc-dva.html.
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.